AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Dapagliflozin in Kenya
7 products registered with PPB — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GLYDA 5 (Dapagliflozin Tablets 5mg) Tablet | H2026/CTD12010/25036 | Hetero Labs Limited | active | 27 Jan 2031 |
| GLYDA 10 (Dapagliflozin Tablets 10mg) Tablet | H2026/CTD12208/25038 | Hetero Labs Limited | active | 27 Jan 2031 |
| DAPAGOOD 10 Tablet | H2025/CTD11872/25888 | ZAIN PHARMA LIMITED | active | 30 Jul 2030 |
| DAPAONE 5 Tablet | H2025/CTD11756/21739 | MSN LABORATORIES PRIVATE LIMITED.. | active | 8 Jul 2030 |
| DAPAONE 10 Tablet | H2024/CTD10371/21743 | MSN LABORATORIES PRIVATE LIMITED.. | active | 6 Mar 2029 |
| Dapzin-5 Tablet | H2022/CTD9153/16367 | Micro Labs Limited | active | 13 Oct 2027 |
| Dapzin-10 Tablet | H2022/CTD8597/16373 | Micro Labs Limited | active | 31 Aug 2027 |
Dapagliflozin — PPB Registration Details
PPB (Kenya) has 7 registered products containing Dapagliflozin, of which 7 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Dapagliflozin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.